Medical News

RSS

New mouse model breakthrough for Alzheimer's disease research

Alzheimer's disease, the primary cause of dementia in the elderly, imposes a tremendous social and economic burden on modern society. In Japan, the burden of the disease in 2050 is estimated to be a half a trillion US dollars, a figure equivalent to the government's annual revenues.

15 Apr 2014

Irvine Scientific announces launch of BalanCD MDCK cell culture medium

Irvine Scientific is pleased to announce the launch of its BalanCD MDCK cell culture medium, a next generation cell culture product responding to today's requirements for media used in cell-based vaccine manufacturing. This new flagship product expands Irvine Scientific's current BalanCD product portfolio of animal component-free and chemically-defined media with the addition of a new purpose-built product.

15 Apr 2014

Young people with epilepsy are more than twice as likely to be poisoned by medication

Children and young adults with epilepsy are more likely to suffer broken bones, burns and poisonings compared to those without the neurological disorder, new research has found.

15 Apr 2014

EventusDx completes $2.72M financing to support development, commercialization of Octava breast cancer tests

Eventus Diagnostics, Inc. today announced completion of a $2.72 million financing. The financing was led by a new family office private investor, and existing investors also participated. Proceeds of the financing will mostly be used to support the continued development and commercialization of the company's Octava breast cancer tests.

15 Apr 2014

Henry Schein launches new iPad online ordering application to help veterinary practitioners

Henry Schein Animal Health, the leading companion animal health distributor in the United States, and the U.S. animal health business of Henry Schein, Inc., announced today that it has launched a new iPad® online ordering application to help veterinary practitioners manage their product purchases.

15 Apr 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a negative currency impact of 3.4%.

15 Apr 2014

Prestige Brands Holdings signs agreement for acquisition of Hydralyte

Prestige Brands Holdings, Inc. today announced the signing of a purchase agreement for the acquisition of Hydralyte in Australia and New Zealand from The Hydration Pharmaceuticals Trust of Victoria, Australia. The acquisition is expected to close, subject to customary closing conditions, during the first quarter of fiscal 2015, which began on April 1, 2014.

15 Apr 2014

First Edition: April 15, 2014

Today's headlines include reports about the Congressional Budget Office's latest estimate of the costs for expanding health insurance.

15 Apr 2014

Kineta, RLB Holdings form joint venture to address unmet medical needs

Kineta, Inc., a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, LLC, which will commercialize promising, high-value compounds in selective disease areas with unmet medical needs.

15 Apr 2014

Effects of PectaSol-C modified citrus pectin in prostate cancer patients to be studied in phase III trial

A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now recruiting participants to study the effects of dietary supplement PectaSol-C modified citrus pectin (MCP) in controlling prostate specific antigen (PSA) levels in prostate cancer patients.

15 Apr 2014

New initiative aims to develop Global Psoriasis Atlas

While studies over the recent years have contributed to an improved understanding of psoriasis, there are still significant gaps in knowledge related to the epidemiology of this serious, chronic disease and trends in incidence over time. The World Health Organization, reported in 2013 that the worldwide prevalence of psoriasis is around 2%, but that studies in developed countries have declared prevalence rates of more than twice the global estimate at an average of 4.6% .

15 Apr 2014

Reverse Medical receives FDA IDE approval for BARREL Vascular Reconstruction Device

Reverse Medical Corporation today announced FDA IDE approval for clinical investigation of their BARREL Vascular Reconstruction Device (VRD). The BARREL Vascular Reconstruction Device is designed for use with occlusive devices in the treatment of intracranial bifurcation aneurysms.

15 Apr 2014

Sanofi Korea launches gut health product, Probi Digestis

Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of Probi´s gut health product, Probi Digestis starting in April 2014. Probi has already delivered products and received substantial orders for the coming quarters.

15 Apr 2014

Particular brand of helmet affects athlete's risk of suffering from sport-related concussion

Alison Brooks, MD, MPH, a sports medicine physician and faculty member at the University of Wisconsin School of Medicine and Public Health, will present, "Incidence of Sport-Related Concussion in High School Football Players: Effect of Helmets, Mouthguards, Previous Concussions, Years Playing Experience" last week at the 23rd Annual Meeting of the American Medical Society for Sports Medicine (AMSSM) at the Hyatt Regency in New Orleans, La.

15 Apr 2014

Study of VA hospitals finds experienced nurses are most cost-effective

When it comes to the cost and quality of hospital care, nurse tenure and teamwork matters. Patients get the best care when they are treated in units that are staffed by nurses who have extensive experience in their current job, according to a study from researchers at Columbia University School of Nursing and Columbia Business School.

15 Apr 2014

New data focuses on different approaches to improve diagnosis and treatment of HCC

Epidemiological, genetic and clinical data presented today at the International Liver CongressTM 2014 are collectively focussed on different approaches designed to improve the diagnosis, staging and treatment of hepatocellular carcinoma (HCC).

15 Apr 2014

Antibiotics present a safe option for treating children with uncomplicated acute appendicitis

Using antibiotics alone to treat children with uncomplicated acute appendicitis is a reasonable alternative to surgery that leads to less pain and fewer missed school days, according to a pilot study.

15 Apr 2014

Psychological support for diabetes patients: an interview with Katharine Barnard, University of Southampton

It’s been over a decade since the first Diabetes Attitudes Wishes and Needs (DAWN) study showed that psychosocial aspects of diabetes pose specific challenges and barriers to optimal glycaemic control for people living with diabetes.

15 Apr 2014

Study shows how infection worsens damage caused by stroke

Infection is bad news for all of us - but it can be really serious to people who have had a stroke. Evidence is mounting that infection makes things much worse after a stroke.

15 Apr 2014

Viewpoints: Sebelius withstood attacks, but wasn't 'warrior' for law; Burwell offers GOP chance to focus on law's problems

Kathleen Sebelius was known for her patience and cool under savage attack by Republicans, who treated her as a stand-in for the health law. She sat through hearings calmly reciting talking points while they fumed and fulminated for their audience. But that turned out to be one of her biggest liabilities ... What the health law needed in its first years was a cheerful, populist warrior who could laugh at the truly ridiculous distortions and lies Republicans invented about it, and roar back with the truth. Instead, she came across as a mild technocrat. She never emerged from the defensive crouch she assumed after the law's calamitous debut (David Firestone, 4/11).

15 Apr 2014

Medical News

New mouse model breakthrough for Alzheimer's disease research

Irvine Scientific announces launch of BalanCD MDCK cell culture medium

Young people with epilepsy are more than twice as likely to be poisoned by medication

EventusDx completes $2.72M financing to support development, commercialization of Octava breast cancer tests

Henry Schein launches new iPad online ordering application to help veterinary practitioners

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Prestige Brands Holdings signs agreement for acquisition of Hydralyte

First Edition: April 15, 2014

Kineta, RLB Holdings form joint venture to address unmet medical needs

Effects of PectaSol-C modified citrus pectin in prostate cancer patients to be studied in phase III trial

New initiative aims to develop Global Psoriasis Atlas

Reverse Medical receives FDA IDE approval for BARREL Vascular Reconstruction Device

Sanofi Korea launches gut health product, Probi Digestis

Particular brand of helmet affects athlete's risk of suffering from sport-related concussion

Study of VA hospitals finds experienced nurses are most cost-effective

New data focuses on different approaches to improve diagnosis and treatment of HCC

Antibiotics present a safe option for treating children with uncomplicated acute appendicitis

Psychological support for diabetes patients: an interview with Katharine Barnard, University of Southampton

Study shows how infection worsens damage caused by stroke

Viewpoints: Sebelius withstood attacks, but wasn't 'warrior' for law; Burwell offers GOP chance to focus on law's problems

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News